Non-invasive Ventilation and Physical Activity

November 19, 2020 updated by: Dr. Dries Testelmans, Universitaire Ziekenhuizen KU Leuven

Non-invasive Ventilation and Physical Activity in Patients With Neuromuscular Disorders and Thoracic Wall Disorders

As fatigue and daytime sleepiness are typical symptoms of alveolar hypoventilation in patients with neuromuscular disorders and thoracic deformations, we hope, by starting non-invasive ventilation and improving these symptoms, to increase their physical activity.

Study Overview

Status

Terminated

Intervention / Treatment

Detailed Description

Patients with neuromuscular disorders and thoracic deformations develop alveolar hypoventilation during their disease progression. At that time, non-invasive ventilation(NIV) can be started as treatment.

Fatigue and daytime sleepiness are typical symptoms of alveolar hypoventilation. NIV has the intention to improve these symptoms but no research has been performed whether these improvements also objectively improve physical activity. Further on, no research has been performed on muscle strength and muscle fatigue.

Patients' physical activity, physical capacity and sleep quality will be measured before NIV initiation, after 3 months and 1 year of NIV use.

To start NIV, patients will be admitted to our sleep laboratory for 5 days/4 nights. Polysomnography will be used during NIV titration.

Physical activity will each time be measured by 2 activity monitors during 5 days.

Study Type

Interventional

Enrollment (Actual)

8

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Leuven, Belgium, 3000
        • UZ Leuven

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • restrictive pulmonary function test AND
  • symptoms of nocturnal alveolar hypoventilation or
  • increased daytime pressure of arterial CO2 (PaCO2) (>45 mmHg) or
  • >= 10 mmHg increase in PaCO2 during sleep in comparison to a normal awake supine value

Exclusion Criteria:

  • patients < 16 years
  • severe cardiac arrythmias or conduction disturbances
  • severe mental disturbances
  • amyotrophic lateral sclerosis
  • total wheelchair-dependent patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Patients with RLD initiating NIV
Patients with RLD initiating NIV according to Belgian Health guidelines are followed-up before and after NIV initiation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Average daily walking time
Time Frame: Measured before initiation of NIV
Average daily walking time will be measured by the McRoberts physical activity monitor
Measured before initiation of NIV
Average daily walking time
Time Frame: Measured after 3 months of NIV
Average daily walking time will be measured by the McRoberts physical activity monitor
Measured after 3 months of NIV
Average daily walking time
Time Frame: Measured after 1 year of NIV
Average daily walking time will be measured by the McRoberts physical activity monitor
Measured after 1 year of NIV

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in functional exercise capacity
Time Frame: Before NIV initiation
Six minute walking test
Before NIV initiation
Change in muscle strength
Time Frame: Before NIV initiation
Quadriceps muscle strength will be measured by magnetic stimulation. MicroFet measurements of wrist flexion/extension and ankle dorsiflexion/plantar flexion Respiratory muscle strength will be measured by maximal inspiratory pressure and sniff nasal inspiratory pressure
Before NIV initiation
Change in quadriceps fatiguability
Time Frame: Before NIV intiation
Use of magnetic stimulation before and after performing fatigue test of the quadriceps muscle
Before NIV intiation
Change in sleep structure and quality of sleep
Time Frame: Before NIV intiation
Full polysomnography will be used to get insight in sleep improvement
Before NIV intiation
Change in functional exercise capacity
Time Frame: After 3 months of NIV use
Six minute walking test
After 3 months of NIV use
Change in functional exercise capacity
Time Frame: After 1 year NIV use
Six minute walking test
After 1 year NIV use
Change in muscle strength
Time Frame: After 3 months of NIV use
Quadriceps muscle strength will be measured by magnetic stimulation. MicroFet measurements of wrist flexion/extension and ankle dorsiflexion/plantar flexion Respiratory muscle strength will be measured by maximal inspiratory pressure and sniff nasal inspiratory pressure
After 3 months of NIV use
Change in muscle strength
Time Frame: After 1 year NIV use
Quadriceps muscle strength will be measured by magnetic stimulation. MicroFet measurements of wrist flexion/extension and ankle dorsiflexion/plantar flexion Respiratory muscle strength will be measured by maximal inspiratory pressure and sniff nasal inspiratory pressure
After 1 year NIV use
Change in quadriceps fatiguability
Time Frame: After 3 months of NIV use
Use of magnetic stimulation before and after performing fatigue test of the quadriceps muscle
After 3 months of NIV use
Change in quadriceps fatiguability
Time Frame: After 1 year NIV use
Use of magnetic stimulation before and after performing fatigue test of the quadriceps muscle
After 1 year NIV use
Change in sleep structure and quality of sleep
Time Frame: After 3 months of NIV use
Full polysomnography will be used to get insight in sleep improvement
After 3 months of NIV use
Change in sleep structure and quality of sleep
Time Frame: After 1 year NIV use
Full polysomnography will be used to get insight in sleep improvement
After 1 year NIV use

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dries Testelmans, MD, PhD, Universitaire Ziekenhuizen KU Leuven
  • Study Director: Bertien Buyse, MD,PhD, Universitaire Ziekenhuizen KU Leuven

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2013

Primary Completion (Actual)

February 1, 2017

Study Completion (Actual)

June 1, 2017

Study Registration Dates

First Submitted

December 9, 2013

First Submitted That Met QC Criteria

October 28, 2016

First Posted (Estimate)

November 1, 2016

Study Record Updates

Last Update Posted (Actual)

November 23, 2020

Last Update Submitted That Met QC Criteria

November 19, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • S54220

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neuromuscular Diseases

Clinical Trials on NIV

3
Subscribe